Government loses case claiming $325M over generic Plavix delay
Please login to bookmark Close
 Acting Justice Arthur Emmett 2020-04-28 6:05 pm By Miklos Bolza Sydney
Make us a preferred source
Make us a preferred source
Please login to bookmark Close

A court has dismissed a claim by the Australian Government for $325 million against pharmaceutical companies Sanofi and Bristol-Myers Squibb allegedly owed for excess subsidies it paid for blood-thinner Plavix as a result of an interlocutory injunction blocking a generic version of the blockbuster drug.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact [email protected]